Bellicum Announces Favorable Interim Event-Free Survival Data for Rivo-cel Treated Patients in Presentation at ASH … – GlobeNewswire (press release)
Bellicum Announces Favorable Interim Event-Free Survival Data for Rivo-cel Treated Patients in Presentation at ASH …GlobeNewswire (press release)Interim results suggest rivo-cel outcomes were comparable to a control study of transplants from matched …